A Pilot Study of a PhysiOthErapy-based Tailored Intervention for Long COVID (COVID-19)
POETIC
A Pilot Feasibility Study of a Physiotherapy-based Tailored Intervention for Long COVID.
1 other identifier
interventional
15
1 country
2
Brief Summary
The purpose of this study is to determine the benefits and feasibility of physiotherapy in the recovery of ongoing symptoms after COVID-19 illness. Long COVID Syndrome (Long COVID) is defined by persistent symptoms (including breathlessness, chest pain and fatigue) after COVID-19 illness that continue for more than 12 weeks and cannot be explained by another diagnosis. The goal of this project is to explore physiotherapy as treatment for patients suffering from Long COVID.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable covid19
Started Mar 2022
Longer than P75 for not_applicable covid19
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2021
CompletedFirst Posted
Study publicly available on registry
September 10, 2021
CompletedStudy Start
First participant enrolled
March 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedAugust 29, 2023
November 1, 2022
1.4 years
September 8, 2021
August 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility (patient recruitment and retention rate)
Feasibility will be determined by recruitment of 12 participants within 3 months, retention of \>70% of participants and mean completion of \>70% of all supervised physiotherapy sessions.
120 days
Secondary Outcomes (5)
Quality of life (QOL)
120 days
Self-reported functional status
120 days
Self-efficacy for symptom management
120 days
Six-minute walk test
120 days
One-minute sit-to-stand test
120 days
Study Arms (1)
Outpatient Physiotherapy Intervention
EXPERIMENTALPOETIC will test a patient-oriented, outpatient physiotherapy intervention tailored to each patient based on their symptoms, functional limitations, and goals. The intervention consists of eight one-on-one, supervised sessions delivered over 8 to 10 weeks, approximately one week apart. Each session will be approximately one hour long.
Interventions
Interventions will include: 1. Education and self-management strategies, including the use of wearable activity and real-time heart rate monitors, to safely guide pacing and activity. 2. Breathing pattern education and retraining (including diaphragmatic, relaxed, and paced breathing exercises). 3. Return-to-activity exercise programming (e.g., postural, aerobic, and whole-body strengthening exercises).
Eligibility Criteria
You may qualify if:
- Participant has English language fluency (approximately grade 8-10 reading level) and is able to provide informed consent.
- Participant is an adult (aged ≥ 18 years).
- Confirmed diagnosis of COVID-19 via a positive nasopharyngeal or throat swab within the past 12 months.
- Persistent symptoms lasting ≥12 weeks since the first positive test, including dyspnea (new or increased from baseline as measured by modified Medical Research Council (mMRC) score ≥1).
- Normal oxygen saturation (greater than 90%) by pulse oximetry at rest on room air.
- Participant owns a smart phone, tablet, or computer, and has or is willing to create an email address (for links to REDCap and Zoom).
You may not qualify if:
- Abnormal pulmonary function testing (FEV1/FVC ratio \<70, total lung capacity \<80% predicted, or diffusing capacity \<70% predicted).
- Pre-existing diagnosis chronic lung disease (Interstitial lung disease, COPD, bronchiectasis, or moderate to severe asthma).
- Pulmonary embolism.
- Parenchymal abnormalities on chest radiograph, deemed clinically significant by the pulmonologist.
- Acute or chronic cardiac disease by medical history (myocardial infarction, myocarditis, cardiomyopathy, arrhythmia, moderate or severe valve disease, ventricular dysfunction).
- Syncope at rest or exertion (which could indicate clinically significant cardiac disease).
- Pre-existing diagnosis of a post-viral fatigue syndrome, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) or fibromyalgia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Alberta Health servicescollaborator
Study Sites (2)
Peter Lougheed Centre (PLC), University of Calgary
Calgary, Alberta, T1Y 6J4, Canada
Rockyview General Hospital, University of Calgary
Calgary, Alberta, T2V 1P9, Canada
Related Publications (1)
Lo M, Eiriksson L, Hunter S, Twomey R, Skolnik K, Chen J, Afshar EE, Weatherald J, Lim RK. Individually Tailored Physiotherapy in Persons With Respiratory Symptoms Related to Post-Acute Sequelae of COVID-19: A Feasibility Study With Mixed Methods. Health Sci Rep. 2025 Oct 21;8(10):e71367. doi: 10.1002/hsr2.71367. eCollection 2025 Oct.
PMID: 41132192DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Weatherald, MD, MSc
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2021
First Posted
September 10, 2021
Study Start
March 4, 2022
Primary Completion
August 9, 2023
Study Completion
November 30, 2023
Last Updated
August 29, 2023
Record last verified: 2022-11